Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104 (HEB-PEP)

2024-518355-36-01 Human pharmacology (Phase I) - First administration to humans Ongoing, recruiting

Start 27 Nov 2024 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - First administration to humans
Status Ongoing, recruiting
Participants planned 24
Countries 1
Sites 1

chronic Hepatitis B

Key facts

Sponsor
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Participant type
Patients
Age range
18-64 years
Gender
Male and Female
Therapeutic area
Diseases [C] - Virus Diseases [C02]
Trial duration
27 Nov 2024 → ongoing
Decision date (initial)
2024-11-27
Transition trial
Yes
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

External identifiers

EU CT number
2024-518355-36-01
EudraCT number
2022-002194-28
ClinicalTrials.gov
NCT05841095

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

chronic Hepatitis B

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Sponsor organisation
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Address
Dr. Molewaterplein 40
City
Rotterdam
Postcode
3015 GD
Country
Netherlands

Scientific contact point

Organisation
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Contact name
Sonja buschow

Public contact point

Organisation
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Contact name
Roel Pieterman

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Netherlands Ongoing, recruiting 24 1
Rest of world 0

Investigational sites

Netherlands

1 site · Ongoing, recruiting
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Gastroenterology and hepatology, Dr. Molewaterplein 60, 3015 GJ, Rotterdam

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Netherlands 2024-11-27 2024-11-27

Application history

2 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-11-06 Netherlands Acceptable
2024-11-27
2024-11-27
2 SUBSTANTIAL MODIFICATION SM-1 2025-07-21 Netherlands Acceptable
2025-09-16
2025-09-22